We are live on ! Find out more
BBNX

Beta Bionics

158 hedge funds and large institutions have $1.44B invested in Beta Bionics in 2025 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 16

103% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 30

50% more capital invested

Capital invested by funds: $963M → $1.44B (+$477M)

22% more funds holding

Funds holding: 129158 (+29)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

3.96% less ownership

Funds ownership: 111.22%107.26% (-4%)

Holders
158
Holders Change
+29
Holders Change %
+22.48%
% of All Funds
1.92%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
46
Increased
61
Reduced
30
Closed
16
Calls
$320K
Puts
Net Calls
+$320K
Net Calls Change
+$320K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$12.4M +$164K +6,155 +2%
JP Morgan Chase
27
JP Morgan Chase
New York
$10.6M +$3.81M +142,716 +69%
Norges Bank
28
Norges Bank
Norway
$10.3M +$9.06M +339,300 New
Charles Schwab
29
Charles Schwab
California
$10.1M +$24.9K +931 +0.3%
Citadel Advisors
30
Citadel Advisors
Florida
$9.78M +$8.57M +320,880 New
Northern Trust
31
Northern Trust
Illinois
$8.67M -$363K -13,607 -5%
PVI
32
Pura Vida Investments
New York
$8.57M
Tudor Investment Corp
33
Tudor Investment Corp
Connecticut
$7.91M +$5.9M +221,039 +573%
First Eagle Investment Management
34
First Eagle Investment Management
New York
$7.73M +$547K +20,500 +9%
UBS Group
35
UBS Group
Switzerland
$7.66M +$3.3M +123,533 +97%
Marshall Wace
36
Marshall Wace
United Kingdom
$6.95M -$9.8M -366,946 -62%
EIM
37
Essex Investment Management
Massachusetts
$6.64M -$129K -4,819 -2%
Raymond James Financial
38
Raymond James Financial
Florida
$6.32M -$170K -6,353 -3%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$6.27M +$2.98M +111,610 +118%
BNP Paribas Financial Markets
40
BNP Paribas Financial Markets
France
$6.15M +$5.18M +194,077 +2,483%
Voloridge Investment Management
41
Voloridge Investment Management
Florida
$4.62M +$3.43M +128,301 +550%
SG Americas Securities
42
SG Americas Securities
New York
$4.58M +$4.01M +150,277 New
Jane Street
43
Jane Street
New York
$4.28M +$2.83M +105,978 +306%
FGP
44
Freestone Grove Partners
California
$4.21M +$3.69M +138,138 New
Two Sigma Advisers
45
Two Sigma Advisers
New York
$4.18M +$2.86M +107,000 +354%
GIM
46
Granahan Investment Management
Massachusetts
$3.69M +$948K +35,505 +41%
Invesco
47
Invesco
Georgia
$3.58M +$1.83M +68,640 +141%
TI
48
Trexquant Investment
Connecticut
$3.53M +$3.09M +115,761 New
Bank of New York Mellon
49
Bank of New York Mellon
New York
$3.04M +$258K +9,665 +11%
QT
50
Quantbot Technologies
New York
$2.72M +$2M +75,011 +521%

BBNX Hedge Fund Activity: Q4 2025 in Review

158 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q4 2025, worth a combined $1.44B — up 50% from $963M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new BBNX positions and 16 closed out — a net gain of 30 holders — while 61 added to existing stakes and 30 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $35.4M. The largest seller was Wellington Management Group, exiting entirely with an estimated $77.5M sold.

  • 158 institutional investors held Beta Bionics (BBNX) as of Q4 2025, up from 129 in Q3 2025.
  • Funds reported $1.44B of Beta Bionics stock for Q4 2025, up 50% quarter-over-quarter.
  • 46 funds opened new Beta Bionics positions in Q4 2025 and 16 closed out, a net change of +30 holders.
  • The largest Beta Bionics buyer in Q4 2025 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $35.4M added.
  • The largest Beta Bionics seller in Q4 2025 was Wellington Management Group, an estimated $77.5M sold.

Based on aggregated 13F filings for Q4 2025.